Tag: vaccinations

Categories
Business

Pakistan’s Personal Vaccinations Draw Criticism

Pakistan's Private Vaccinations Draw Criticism

ISLAMABAD, Pakistan – Coronavirus penetrated Pakistan and Muhammad Nasir Chaudhry was concerned. Long lines and scarce supplies plagued the government’s free vaccination campaign. The newspapers were filled with reports of well-connected people jumping in for a free dose.

Then Mr. Chaudhry, a 35-year-old government adviser, discovered that he could pay to skip the long lines himself. He signed up to take two doses of the Russia-made Sputnik V vaccine for about $ 80 from a private hospital. That’s a lot of money in a country where the average worker makes about $ 110 a month, but Mr. Chaudhry was ready to make the commitment.

Critics have attacked such private sales in Pakistan and around the world, claiming that they only make vaccinations available to the rich. But in Pakistan, as elsewhere, scarce supplies have hampered these efforts. The private hospitals are no longer serviced and Mr Chaudhry has still not been vaccinated.

“I’m willing to pay double the price for the vaccine, but I don’t want to keep waiting,” said Chaudhry.

Access to the coronavirus vaccine has shed a lot of light on global inequality. The United States and other rich countries have bought up most of the world’s vaccine supplies to protect their own people and stored millions of doses and left them in places unused. Less developed countries fight over what is left.

To speed up vaccination, some countries have allowed private sales of cans. However, these campaigns have been troubled by supply issues and complaints that merely reflect global differences.

“The Pakistani example is a microcosm of what went wrong with the global response – where prosperity alone has primarily shaped access,” said Zain Rizvi, drug access expert at Public Citizen, a Washington advocacy group. DC, in an email. “To end the pandemic, the world community needs to do a lot more than just that.”

India is selling vaccines to private hospitals, although they are looking for supplies now that the pandemic is so severe there. Kenya approved and then blocked private sales over fears that counterfeit vaccines would be sold. In the United States, some well-connected companies like Bloomberg have secured cans for employees.

Indonesia on Tuesday allowed companies to buy vaccines from the government to vaccinate employees and family members for free. The only vaccine approved for this program to date is a Sinopharm vaccine.

Pakistan says the private program could provide more free footage to low-income people. By buying doses of the Russia-made Sputnik 5 vaccine, the country’s rich would not have to get the free doses made by Sinopharm of China. Some people would prefer to get vaccinated in a private hospital as it is widely believed that they are comparatively better organized and more efficient than overburdened government facilities.

Pakistan’s demand is growing. The country of nearly 220 million people reports more than 2,500 new infections daily, but the low testing rate suggests that many more cases go undetected. The government has tightened restrictions and restricted public gatherings.

However, the government’s vaccination campaign has been slow. It has started giving doses to people over 40 this month. Younger people may have to wait several months.

This is due to the scarce global supplies, said Chaudhry Fawad Hussain, Pakistan’s information minister. In addition to the Sputnik and Sinopharm vaccines, Pakistan received 1.3 million doses of the AstraZeneca vaccine earlier this month from Covax, the international organization that promotes vaccination, and is expected to receive 3.5 million doses of the Sinovac vaccine from China by the end of May .

Updated

May 22, 2021, 11:55 a.m. ET

Private sales sparked a fiery debate in a country where the economy has stalled from the pandemic and long-standing problems such as lack of foreign investment and high national debt. Critics say the decision will deepen divisions within the country, where much of society lives below the poverty line.

“The government did not think about the suffering of the poor while allowing importers to sell the vaccine,” said Dr. Mirza Ali Azhar, a director of the Pakistan Medical Association, the nationwide medical professional organization. “Such discriminatory policies will increase feelings of disadvantage among poor young people, especially those with weak immune systems.”

Information minister, Mr Chaudhry, downplayed the pricing problem, saying that private vaccines could not respond to public needs anyway.

The initiative has encountered another problem: hospitals cannot find vaccines for sale. The demand was strong. The government sets a price cap but has been embroiled in a dispute with private importers over how much that should be.

Long lines formed in Karachi city in April when two private hospitals began selling the Sputnik V vaccine to walk-ins. Private hospitals in Islamabad, the capital, and Lahore faced a similar onslaught of people and were in short supply within days. Hospitals in major cities have stopped taking walk-ins and online registration has also been suspended.

Sputnik V isn’t the only vaccine the government is selling privately. A one-time shot of CanSino Biologics from China costs around $ 28. Demand was weaker due to greater public confidence in the Russian vaccine. Even so, supplies quickly sold out after the CanSino cans went on sale last month. The government has announced that another 13.2 million cans will arrive in June.

AGP Limited, a private pharmaceutical company that has imported 50,000 doses of Sputnik, urges patience.

“Sputnik V received an overwhelming response in Pakistan: thousands of people were vaccinated in a matter of days, and an even higher number of registrations were confirmed in hospitals across Pakistan,” said Umair Mukhtar, a senior official at AGP Limited. He said the company had placed large orders for more.

The state price dispute could delay further expansion. The Medicines Agency wants Sputnik V to be sold at a lower price. AGP received an injunction to sell the vaccine on April 1, pending a final price.

For those who can afford the cans, frustration grows. Junaid Jahangir, an Islamabad-based lawyer, said several of his friends had been given private vaccinations. He registered with a private laboratory for Sputnik V, but later received a text message stating that the vaccination campaign had been interrupted.

“I will be denied a fair chance to fight this virus if I get infected,” Jahangir said. “The demand is there and I don’t see what could possibly be the reason for the inefficiency of the supply.”

Some of the people who paid for private cans based their decision on media reports that some well-connected people jumped the line to get free public cans. In May, Lahore authorities suspended at least 18 low-ranking health workers for vaccinating people after accepting out of line bribes.

Actor and talk show host Iffat Omar publicly apologized in April for being ahead of the curve to get the vaccine. “I’m sorry,” she said on Twitter. “I am ashamed. I apologize with all my heart. I will repent.”

Fiza Batool Gilani, an entrepreneur and daughter of Yusuf Raza Gilani, the former prime minister, said she knows several young people who have queued and received the free government vaccine in recent weeks.

“I was offered a free vaccine myself, but declined because I wanted to get the private vaccine,” said Ms. Gilani. Wealthy people should pay for their cans, she said, adding that for CanSino shots, her family would pay for housekeeping.

Many people like Tehmina Sadaf don’t have this option.

Ms. Sadaf, 35, lives with her husband and a seven-year-old son in a working-class neighborhood on the outskirts of Islamabad. Her husband is a clergyman in a mosque. She teaches Koran to young children. She said the pandemic had a negative impact on family income by around $ 128 a month. “After we pay the rent and the electricity bill, we don’t have much choice,” she said.

She had her doubts about the public vaccine, “but the price of the private vaccine is very high,” she said. “It should have been lower so that poor people like us could also afford it.”

Zia ur-Rehman reported from Karachi, Pakistan. Richard C. Paddock and Muktita Suhartono contributed to the coverage.

Categories
Business

Japan’s Yo-Yoing Financial system Shrinks as Virus Spreads and Vaccinations Lag

Japan’s Yo-Yoing Economy Shrinks as Virus Spreads and Vaccinations Lag

Japan’s economy contracted in the first three months of 2021 and continued to alternate between growth and contraction as the vaccination campaign threatened to hold back recovery from the pandemic, although other major economies appeared poised for rapid growth.

In about a year since the coronavirus emerged, Japan’s domestic demand has seen cycles of shrinking and expansion as coronavirus cases have risen and consumers have withdrawn indoors and then infections have receded and businesses have welcomed customers back to have.

Japan is currently experiencing a resurgence of virus cases with much of the country in a state of emergency and the number of deaths rising, particularly in Osaka. According to analysts, the yo-yo economic pattern is unlikely to stop until the country has vaccinated a significant portion of its population. These efforts have only just begun and are unlikely to accelerate significantly in the months ahead.

These dynamics could potentially drag the country back into recession – defined as two consecutive quarters of contraction – later this year as it struggles to control the spread of more deadly and contagious variants of coronavirus.

Japan’s economy, the third largest in the world after the US and China, contracted 1.3 percent from January to March, an annual decline of 5.1 percent. The contraction followed two consecutive quarters of expansion.

Growth skyrocketed in the second half of last year as consumers who had holed up at home for months to avoid the virus piled into department stores, restaurants, bars and theaters.

The recovery went a long way in getting the economy out of the huge hole that formed in the early months of the pandemic. However, as the new data shows, the turnaround is fragile and will be difficult to sustain as long as the country continues to face the threat from the virus.

“We are in a situation where we cannot relax until the vaccine is well distributed,” said Keiji Kanda, senior economist at the Daiwa Institute of Research in Tokyo.

In early 2020, when the pandemic hit, Japan’s economy was already battling headwinds from falling demand from China, a hike in consumption tax, and a devastating typhoon. When the country plunged into distress this spring, domestic consumption crumbled and exports fell to new lows.

The result was the biggest blow to the economy since 1955, when the country first began using gross domestic product to measure its growth.

Even so, the impact of the pandemic on Japan was relatively minor compared to the devastation in the US and many European countries. Japan has never been completely locked down and the total death toll remains below 12,000.

Updated

May 17, 2021, 6:24 p.m. ET

These factors, combined with – by some measures – the world’s largest stimulus measures, have kept the country’s unemployment rate low and propped up many small businesses such as restaurants and hotels.

While Japan’s pandemic response has managed to mitigate the worst of the economic damage, the recovery will continue to be an uphill battle, said Tomohiro Ota, senior economist at Goldman Sachs in Japan.

Trade has rebounded in recent months as some countries reopened, but “without a recovery in consumption we cannot go back to the days before Covid,” he said.

To achieve this goal, two steps forward and one step back had to be taken. Home consumption has increased in waves that increase and decrease as the number of cases increases.

Japan’s state of emergency last spring devastated domestic demand when people stashed at home. Consumption recovered briefly in summer and autumn. A similar upswing followed a second state of emergency in January.

Last month, authorities put the country in dire straits for the third time to review the spread of the coronavirus ahead of the Olympics, which are slated to begin in Tokyo in late July.

The latest round of restrictions only affects parts of the country, but also includes major metropolitan areas such as Tokyo and Osaka and is stricter than the previous one. Earlier iterations focused on shortening the opening times of bars and restaurants. In this version, for the first time, officials demanded that department stores restrict most services and that restaurants stop serving alcohol.

The economic impact of the measures will depend on the response of a public already tired of staying home, said Taro Saito, an executive research fellow at the NLI Research Institute in Tokyo.

“We cannot say with certainty that there will be a contraction between April and June,” he said because of the restrictions. But “if the target areas expand, this could put pressure on growth. The situation is very fluid. “

The stop-and-go pattern is likely to repeat itself for some time, said Izumi Devalier, Japan’s chief economist at Bank of America Merrill Lynch.

“The domestic economy continues to be affected by developments surrounding the virus,” Devalier said, adding that vaccination remained key to improving domestic demand.

Japan’s vaccine rollout was one of the slowest among major industrialized nations. Authorities have approved the use of only one vaccine, made by Pfizer and BioNTech, and strict regulations that require vaccinations to be given by doctors and nurses have slowed its spread. Just over 3 percent of the country has received an initial shot, and vaccines are unlikely to be made available to the general population until late this summer at the earliest.

“Japan is way behind other countries that were in their vaccination programs at the time,” Ms. Devalier said, adding that slow progress “simply delays recovery.”

Mr. Kanda of the Daiwa Institute of Research said, “If vaccination makes good progress, economic activity can basically resume from fall this year.”

But, he added, “if the current pace continues, we could see another explosion of infections.”

Categories
Business

Pandemic removed from over regardless of vaccinations

Pandemic far from over despite vaccinations

Family members of Vijay Raju, who died due to Covid, mourn before his cremation in the village of Giddenahalli on the outskirts of Bengaluru, India, on May 13, 2021.

Samuel Rajkumar | Reuters

The global pandemic is not over yet, despite high Covid vaccination rates in some countries, the head of the World Health Organization warned on Monday, days after the CDC told fully vaccinated Americans that they could go without a mask in most places.

“There is a tremendous hiatus where in some countries with the highest vaccination rates the pandemic appears to be over while others are experiencing large waves of infection,” WHO Director General Tedros Adhanom Ghebreyesus said during a news conference from the agency’s headquarters in genf.

“The pandemic is far from over,” he warned. “It won’t be over anywhere until it’s over everywhere.”

Tedros’ comments came four days after the Centers for Disease Control and Prevention updated their public health guidelines to say that fully vaccinated people no longer wear face masks in most settings, whether outdoors or indoors, or 6 Need to stay away from others. It’s the first time the federal government has been encouraging people to stop wearing masks since the agency first called for face coverings more than a year ago.

Some doctors said the new guidelines mean “people who have been vaccinated can go back to normal”.

In the United States, new Covid cases are on the decline as more Americans get vaccinated. As of Sunday, the nation reports about 33,200 new infections daily based on a 7-day average of data compiled by Johns Hopkins University, a 19% decrease from a week earlier. According to the CDC, around 123 million Americans are fully vaccinated.

Major outbreaks occur in other countries. India, for example, reports an average of around 328,900 cases per day for seven days as of Sunday, according to Hopkins. That’s 15% less than a week ago, but it’s still an enormous number of cases. The country also hit a new record of deaths, reporting an average of 4,039 deaths in seven days, according to Hopkins data.

Tedros said the agency has responded to the surge in India and other hot spots around the world. He said WHO needed immediate funding to maintain its technical and operational support to all countries, especially those hardest hit by the pandemic.

“The current response plan is underfunded and the vast majority of it is earmarked by donors for specific countries or activities,” he said.

He also urged Covid’s vaccine makers, including Pfizer and Moderna, to make more vaccines available to COVAX, which doses poorer countries.

“We need cans now and we urge them to move forward with deliveries as soon as possible,” he said.

Categories
Business

UK prepares surge vaccinations to sort out Covid variant from India

Oxford to launch human challenge trial to study immune response

Caroline Nicolls will receive an injection of the Moderna Covid-19 vaccine administered by Sister Amy Nash at Madejski Stadium in Reading, west of London, on April 13, 2021.

STEVE PARSONS | AFP | Getty Images

LONDON – UK is preparing to have vaccinations and tests carried out in areas where the new variant of Covid-19, first discovered in India, is spreading.

Vaccine Minister Nadhim Zahawi told BBC TV on Friday that the government would “bend” its vaccination program to target more doses to the hardest hit areas, while second doses could be brought forward.

In a statement late Thursday, the UK Department of Health and Welfare announced that a new surge rapid response team of 100 nurses, health advisors and environmental health officers would be deployed to Bolton, a town on the outskirts of Manchester. where variant B1.617.2 spreads quickly.

“While there is still no clear evidence that this variant has a greater impact on disease severity or evades the vaccine, the rate of growth matters and the government is considering additional measures if deemed necessary, including the best possible Using the vaccine role-out to best protect the most vulnerable in the context of the current epidemiology, “the department said in the statement.

Surge testing, along with improved genome sequencing and contact tracing, is also being rolled out to other areas across the country.

Data on the new variant, released Thursday by Public Health England, showed the number of cases across the UK rose from 520 last week to 1,313 this week, with most cases in the north-west of England and some clusters concentrated in London.

New restrictions cannot be ruled out

The introduction of vaccines in the UK was one of the fastest in the world. Almost 70% of the adult population have received at least one shot to date. Vaccines are currently available to people over the age of 38. However, the government has stated that they could be made available to younger people in multi-generational households.

The next phase of England’s exit from the lockdown is slated for Monday, when the conviviality, hospitality and indoor entertainment will resume.

However, Health and Welfare Secretary Matt Hancock said in a statement Thursday that the government is “monitoring the situation very carefully and does not hesitate to take further action if necessary”.

With the special unit in Bolton, surge tests have already been carried out in 15 areas across England, with more than 800,000 tests distributed.

“As outlined in the roadmap, we cannot rule out the possibility that economic and social restrictions will be reimposed at local or regional level if there is evidence that they are necessary to contain or suppress a variant that escapes the vaccine”, said the DHSC.

Categories
Business

Seychelles Sees Rise in Coronavirus Circumstances Regardless of Vaccinations

Seychelles Sees Rise in Coronavirus Cases Despite Vaccinations

Marie Neige, a call center operator in the Seychelles, really wanted to be vaccinated. Like the majority of residents of the tiny island nation, she received China’s Sinopharm vaccine in March and should be fully protected in a few weeks.

She tested positive for the coronavirus on Sunday.

“I was shocked,” said Ms. Neige, 30, who is isolated at home. She said she had lost her sense of smell and taste and had a slight sore throat. “The vaccine should protect us – not from the virus, but from the symptoms,” she said. “I took precautionary measures after precautionary measures.”

China expected its Sinopharm vaccines to be the linchpin of the country’s vaccine diplomacy program – an easy-to-carry dose that would protect not only Chinese citizens but much of the developing world as well. China has donated 13.3 million doses of Sinopharm to other countries to gain goodwill, according to Bridge Beijing, a consulting firm tracking China’s impact on global health.

Instead, the company that made two types of coronavirus vaccines faces growing questions about the vaccinations. First, there was a lack of transparency in the late-stage experimental data. Now, Seychelles, the world’s most vaccinated nation, has seen increases in some cases, despite the fact that much of its population has been vaccinated with Sinopharm.

For the 56 countries that are counting on Sinopharm’s shot to stop the pandemic, the news is a setback.

For months, public health experts had focused on bridging the access gap between rich and poor nations. Now scientists are warning that developing countries that choose to use the Chinese vaccines, with their relatively weaker efficacy rates, could lag behind those choosing vaccines from Pfizer-BioNTech and Moderna. This loophole could allow the pandemic to continue in countries with fewer resources to fight the pandemic.

“You have to be using really powerful vaccines to get this economic benefit or you will be living with the disease long term,” said Raina MacIntyre, who heads the biosecurity program at the Kirby Institute, University of New South Wales in Sydney, Australia. “The choice of vaccine is important.”

Nowhere have the consequences been more apparent than in the Seychelles, which relied heavily on a Sinopharm vaccine to vaccinate more than 60 percent of their population. The tiny island nation in the Indian Ocean, northeast of Madagascar and with a little over 100,000 inhabitants, is fighting a wave of the virus and had to impose another lockdown.

Of the vaccinated population who received two doses, 57 percent received Sinopharm while 43 percent received AstraZeneca. Thirty-seven percent of the new active cases, according to the Ministry of Health, are fully vaccinated people who did not indicate how many people among them received the Sinopharm shot.

“At first glance, this is an alarming finding,” said Dr. Kim Mulholland, a pediatrician at Murdoch Children’s Research Institute in Melbourne, Australia who has been involved in overseeing many vaccine studies, including those for a Covid-19 vaccine.

Dr. Mulholland said the first reports from the Seychelles correlate with a 50 percent rate of effectiveness for the vaccine instead of the 78.1 percent rate the company has touted.

“We would expect in a country where the vast majority of the adult population has been vaccinated with an effective vaccine to see the disease melt away,” he said.

Scientists say breakthrough infections are normal because no vaccine is 100 percent effective. The Seychelles experience, however, is in stark contrast to Israel, which has the second highest vaccination rate in the world and has managed to fight back the virus. A study showed that the Pfizer vaccine used by Israel was 94 percent effective at preventing transmission. On Wednesday, the number of new confirmed Covid-19 cases per million people in the Seychelles stood at 2,613.38 compared to 5.55 in Israel, according to The World In Data project.

Updated

May 12, 2021, 12:34 p.m. ET

Wavel Ramkalawan, the President of Seychelles, defended the country’s vaccination program, saying that the vaccines against Sinopharm and AstraZeneca “have served our people very well”. He pointed out that the Sinopharm vaccine was given to people aged 18 to 60, and that in that age group, a total of 80 percent of patients who had to be hospitalized were not vaccinated.

“People may be infected, but they are not sick. Only a small number, ”he told the Seychelles News Agency. “So what happens is normal.”

Minister for Foreign Affairs and Tourism Sylvestre Radegonde said the surge in cases in Seychelles was partly due to people abandoning their vigilance, according to the Seychelles News Agency. Sinopharm did not respond to a request for comment.

In response to a Wall Street Journal article on Seychelles, a Chinese Foreign Ministry spokeswoman accused the Western media of attempting to discredit Chinese vaccines and “cultivating the mentality that” everything related to China must be smeared “.

In a press conference, Kate O’Brien, director of vaccinations at the World Health Organization, said the agency assessed the rise in infections in the Seychelles and called the situation “complicated”. Last week the global health group approved the Sinopharm vaccine for emergency use, raising hopes of an end to the global supply crisis.

She said that “some of the cases that are reported occur either shortly after a single dose, or shortly after a second dose, or between the first and second dose.”

According to Ms. O’Brien, WHO is studying the strains currently circulating in the country, when the cases occurred, relative to when someone was dosed and the severity of each case. “Only through this type of assessment can we judge whether or not it is vaccination failure,” she said.

However, some scientists say it is becoming increasingly clear that the Sinopharm vaccine does not offer a clear path to herd immunity, especially considering the numerous variants that appear around the world.

Governments using the Sinopharm vaccine must “accept a significant failure rate and plan accordingly,” said John Moore, a vaccine expert at Cornell University. “You need to make the public aware that you still have a good chance of getting infected.”

Many in Seychelles say the government was not ready.

“My question is, why did you push everyone to take it?” said Diana Lucas, a 27-year-old waitress who tested positive on May 10th. She said she received her second dose of the Sinopharm vaccine on February 10th.

Government attorney Emmanuelle Hoareau, 22, tested positive on May 6th after the second dose of the Sinopharm vaccine in March. “It doesn’t make sense,” she said. She said the government failed to provide enough information about the vaccines to the public.

“They don’t explain the real situation to people,” she said. “It’s a big deal – a lot of people get infected.”

Ms. Hoareau’s mother, Jacqueline Pillay, is a nurse at a private clinic in Victoria, the capital. She believes there is a new variant in the Seychelles because a lot of foreigners have arrived in the last few months. The tourism-dependent country opened its borders to most travelers without quarantine on March 25.

“People are very scared now,” said Ms. Pillay, 58. “If you gave people the right information, people wouldn’t speculate.”

Health officials recently appeared on television to encourage those who only took the first dose of the Sinopharm vaccine to come back for the second shot. But Ms. Pillay said she was frustrated that the public health officer hadn’t addressed why the vaccines don’t seem to be working as well as they should.

“I think a lot of people don’t come back,” said Ms. Pillay.

Marietta Labrosse, Elsie Chen, and Claire Fu have contributed to the research.

Categories
Health

Fauci Says Indoor Masks Steerage Ought to Ease With Vaccinations

Fauci Says Indoor Mask Guidance Should Ease With Vaccinations

Dr. Anthony S. Fauci said Sunday he was open to relaxing indoor masking rules as more Americans are vaccinated against the virus just two days after the Centers for Disease Control and Prevention belated the risk of airborne transmission had emphasized.

Dr. Fauci, President Biden’s senior medical advisor on the pandemic, said that as vaccinations rise, vaccinations need to “become more liberal” on the rules for wearing masks indoors, despite noting the nation still averaging 43,000 Cases of the virus had daily. “We have to get it way, much lower than that,” he said.

On Friday, the CDC updated its guidelines on the spread of the coronavirus, specifically stating that people can breathe airborne viruses even if they are more than three feet from an infected person. The agency had previously said that most infections were acquired through “close contact, not airborne transmission”.

The update brought the agency in line with evidence of the risk of airborne droplets found by epidemiologists over the course of the pandemic last year, and also underscored the urgency of the federal agency for occupational health and safety, according to some experts Standards for employers issues to address potential airborne hazards in the workplace.

Dr. Fauci’s comments on Sunday came in response to a question on comments Dr. Scott Gottlieb, the former head of the Food and Drug Administration, turned in to CNBC last week. He said that relaxing the mandates for indoor masks now – “especially in settings where you know you have high levels of vaccinations” – would give public health officials “the credibility to implement them again in the fall or winter “When the cases increase again.

Dr. Fauci, when asked if he would agree by George Stephanopoulos on the ABC Sunday program “This Week”, said, “I think so, and I think you will probably see that as we join in and when more people are vaccinated. ”

“The CDC will be in near real-time George updating their recommendations and guidelines,” continued Dr. Fauci gone. “But yes, we have to become more liberal when more people are vaccinated.”

Over a third of the US population – more than 112 million people – is fully vaccinated, and another 40 million people have received the first dose of a two-dose protocol.

The CDC, which issues national guidelines on masking, says even vaccinated people should continue to wear masks in indoor public spaces, including restaurants, when they are not actively eating and drinking. In many places in the country it is clear that the guidelines are not being followed.

In a separate interview on Sunday via CNN’s State of the Union, Jeffrey Zients, Mr. Biden’s Covid response coordinator, was a little more careful than Dr. Fauci, when he was named after Dr. Gottlieb’s comments was asked.

“I think everyone is tired and wearing a mask is – it can be a pain,” said Mr. Zients. “But we’re getting there. And the light at the end of the tunnel is always brighter. Let’s be on guard. Let’s follow CDC guidelines. And CDC guidelines will, over time, give vaccinated people more and more privileges to remove this mask. “

Mr. Zients also suggested that instead of achieving herd immunity – the point at which enough people are immune to the virus that can no longer spread through the population – the goal should be to achieve a sense of normalcy by 70 percent of Americans are vaccinated. President Biden has called for 70 percent to receive at least one dose by July 4th.

Reaching 70 percent will “create a pattern of decreasing cases, hospitalizations and deaths and bring us to sustained low levels,” Zients said, citing Israel, a world leader in vaccinations, as a model.

In that country, vaccinations have reached nearly 60 percent of the population since it began December 19 last year, and the 7-day average of new cases has fallen from a high of more than 8,600 on January 17 to less than 60 by Saturday.

Categories
World News

Vaccinations Rise within the E.U. After a Lengthy, Sluggish Begin

Vaccinations Rise in the E.U. After a Long, Slow Start

Vaccinations are picking up speed in the European Union, an amazing turnaround after the bloc’s vaccination campaign stalled for months.

On average over the past week, nearly three million doses of the Covid-19 vaccine were administered daily in the European Union, a group of 27 nations, according to Our World in Data, an Oxford University database. When adjusted for population, the rate is roughly equivalent to the number of shots per day in the United States, where demand has declined.

The EU vaccination campaign, hampered by interruptions in supplies of the AstraZeneca and Johnson & Johnson Covid-19 vaccines, last month revolved around the Pfizer BioNTech vaccine.

Last month, European Commission President Ursula von der Leyen said Pfizer had agreed to an early delivery of doses that should likely allow the bloc to meet its goal of vaccinating 70 percent of adults by the end of summer. The European Union is also about to announce a contract with Pfizer and its German partner BioNTech for 2022 and 2023 that will include 1.8 billion doses for boosters, variants and children’s vaccines.

The United States acted aggressively as part of the Trump administration’s Operation Warp Speed ​​to raise millions of doses by funding and promoting vaccine production. But the European Union has not partnered with drug manufacturers like the US has, but more like a customer than an investor.

“I think it is overdue that the EU has stepped up its vaccination campaign,” said Beate Kampmann, director of the vaccine center at the London School of Hygiene and Tropical Medicine.

“I think with the number of deaths and new cases in the EU, it is absolutely important that we get the vaccine to the people there very, very quickly,” she added.

The rise of the EU underscores the differences in vaccination efforts around the world.

About 83 percent of Covid shots were given in high- and higher-middle-income countries, while only 0.3 percent of the doses were given in low-income countries. In North America, more than 30 percent of people have received at least one dose, according to Our World in Data. In Europe it is almost 24 percent. In Africa it is just over 1 percent.

Experts warn that if the virus is widespread in large parts of the world without vaccines and threatens all countries, dangerous variants will continue to evolve and spread.

Last week, the Biden government said it supported the waiver of intellectual property protection for Covid vaccines, which would have to be approved by the World Trade Organization. And even then, experts warn that drug companies around the world would need tech help to make the vaccines and time to ramp up production.

European leaders like Ms. von der Leyen and President Emmanuel Macron has made it clear that President Biden should take a different approach and instead lift the export restrictions on vaccines that the United States has used to keep most doses for domestic use. “We call on all vaccine-producing countries to allow exports and to avoid measures that disrupt the supply chain,” said Ms. von der Leyen in a speech last week.

But the matter is not so absolute, said Dr. Thomas Tsai, Professor of Health Policy at Harvard University. “What is really needed is a comprehensive approach,” he said. Abandoning patents is a big long-term step, but lifting export bans would help sooner.

“There is a need to develop a broader strategy,” said Dr. Tsai to vaccinate the world. “We need the same kind of Warp Speed ​​engagement. It’s an investment. “

Dr. Anthony S. Fauci, the Biden government’s top advisor on Covid-19, said on Sunday that the United States and other countries, as well as vaccine manufacturers, need to help particularly address the crisis in India, which is less than 10 percent of the time Population are at least partially vaccinated as the country battles a devastating virus wave.

“Other countries need to step in to either supply the Indians with supplies to make their own vaccines, or to donate vaccines,” said Dr. Fauci in ABC’s “This Week”. “One of the ways to do this is if the big companies that are able to develop vaccines to scale really big are literally given hundreds of millions of doses to reach them.”

Categories
Health

Gottlieb says circumstances will decline, vaccinations monumental achievement

Gottlieb says cases will decline, vaccinations monumental achievement

A vaccination center displays signs and age groups for Pfizer and Moderna vaccines as California reveals eligibility to vaccinate all residents 16 and older during the coronavirus disease (COVID-19) outbreak in Chula Vista, California, United States on April 15 2021.

Mike Blake | Reuters

Former Food and Drug Administration Commissioner Scott Gottleib said Sunday that a steep decline in new Covid-19 cases in the US is likely to continue and predicted a “relatively calm summer in terms of the spread of coronavirus” .

“Look, the situation in the US continues to improve, and I think the decline in cases will accelerate in the coming weeks,” Gottlieb said on CBS News’ Face the Nation.

The doctor credited the mass vaccination campaign launched under President Donald Trump and continued under President Joe Biden to help stem the spread of the disease.

“This was a monumental achievement – the introduction of this vaccine, the vaccination of so many Americans – and it will go on,” said Gottlieb. “We will keep working on it. The vaccination rate will slow down in the coming weeks. But we will continue to take in more people when we come into the summer.”

To date, more than 100 million Americans have been fully vaccinated against Covid-19, according to the Centers for Disease Control and Prevention, or nearly a third of the population. Approximately 146 million people, or 44% of the population, received at least one dose.

The rate of vaccine administration has declined slightly in the past few weeks after months of spike after receiving one for most of the people who were most likely to want a shot.

As more Americans got vaccines, cases of Covid-19 have fallen sharply. As of Saturday, the 7-day average of daily new cases fell to below 50,000, a decrease of 17% compared to the previous week. Hospital stays and deaths due to the disease are also decreasing.

To get a feel for what might be coming up for the US, Gottlieb said it might be helpful to check out heavily vaccinated San Francisco.

“About 71% of the people in San Francisco had at least one dose of the vaccine, 47% were fully vaccinated. They record about 20 cases a day. You have about 20 people hospitalized,” Gottlieb said.

“They have dramatically reduced Covid in this city and it is largely the result of vaccinations,” he added.

From a financial point of view, Gottlieb suggested that the profits from vaccination were “stalled” and “fairly sustainable”.

“We are entering warm months in which this will create a setback against the spread of the coronavirus, and we are securing these profits,” said Gottlieb.

Even if the health situation in the USA is on the verge of normal, it is deteriorating in other countries with fewer resources. In India, the new daily cases exceeded 400,000 on Saturday, a record.

Disclosure: Scott Gottlieb is a CNBC employee and a member of the boards of directors of Pfizer, genetic testing startup Tempus, health technology company Aetion Inc., and biotech company Illumina. He is also co-chair of the Healthy Sail Panel for Norwegian Cruise Line Holdings and Royal Caribbean.

Subscribe to CNBC Pro for the live TV stream, deep insights and analysis of how to invest over the next president’s term.

Categories
Business

Covid vaccinations in U.S. are slowing as provide outstrips demand

Covid vaccinations in U.S. are slowing as supply outstrips demand

After months of steady surge in vaccinations, the US is seeing its first real slowdown in the daily rate of fire, an indication that the nation is entering a new phase in its vaccination campaign.

More than half of American adults have now received at least one dose, a significant achievement, but vaccinating the second half presents other challenges. Previous vaccinations are likely made up largely of groups who wanted and had the greatest access to the vaccine, and as progress continues, it is no longer about meeting the demand for vaccination.

“We have had vaccinations against those who are most at risk and who are most likely to want to be vaccinated as soon as possible,” White House Tsar Covid Jeff Zients told reporters last week. “We will continue these efforts, but we know that we will reach other populations.” Take your time and focus. “

The country averaged 2.6 million reported vaccinations per day for the past week, data from the Centers for Disease Control and Prevention shows, from a peak of 3.4 million reported shots per day on April 13. That number is falling, even if the eligibility is now open to all adults in every state.

The downturn There is a lot of positive vaccination news to follow, said Dr. Jennifer Kates, senior vice president of the Kaiser Family Foundation’s nonprofit health policy group. The federal government has ensured a large supply of vaccines, states have ironed out kinks in their registration systems, and eligibility has opened up to all adults.

Kates says that meeting existing vaccine needs is no longer the biggest challenge.

“We feel like we’ve got to a point where the people who are left are very hard to reach and need help and more education, or those who are resilient and don’t want to,” she said adding, “the Pent-up demand will be met.”

The question is, what will the answer to the slowdown be? “How do the federal, state and private sectors communicate the importance of vaccination to the public?” Asked Kates.

States are seeing a slowdown in demand

In parallel with the nationwide slowdown, the rate of vaccination is falling in many countries. Eleven states have reported a decrease in shots fired for three consecutive weeks or more, according to a CNBC analysis of the CDC data through Sunday.

In West Virginia, which is off to a hot start with its vaccination campaign, the state has passed the tipping point where vaccine supply exceeded demand. The weekly doses have been decreasing for four consecutive weeks.

“If you remember, we were putting a lot of doses in many arms very quickly,” said Maj. Gen. James Hoyer, director of the Joint Interagency Task Force on Vaccines in West Virginia, noting that his state was among the first to get vaccinations have completed among nursing home populations. “There were a lot of people who wanted her and tried very hard to get out and get a vaccine.”

Now, Hoyer said, the state has asked the federal government to dispense doses in smaller vials to reduce the risk of wasting vaccines, which he could not have imagined a few months ago with such a small supply.

“We got the doses and we’re really good at administering them,” said Hoyer. “We are at this stage of educating people who cannot get the vaccine.”

New Mexico led the country for a while, with a greater proportion of the population fully vaccinated than any other state.

But now the state is facing a plateau and finding it harder to fill mass vaccination events, said Matt Bieber, communications director for the state’s health department.

“We’ve been in a period of tons of demand and not enough supply, but now at the point where people who know about the vaccine got it,” he said.

Logistic hurdles

The proportion of Americans who have not yet received a Covid shot is not made up entirely of those who do not want one.

While some oppose it – in a recent Kaiser Foundation survey, 13% of respondents said they would “definitely not” get a vaccine and another 7% said they would only get one if needed – there is, too many groups who have not yet had the resources or the ability to get vaccinated.

“Some people can’t take time off work to get easily vaccinated, or they may not have transportation,” Kates said, explaining that sometimes lack of access is purely logistical. “You literally have no access in the most basic of ways.”

Hoyer said many West Virgins cannot afford to sacrifice hours of wages to leave work for an appointment. His most successful form of public relations has been offering vaccinations to employees and their families in local workplaces, where people can take 30 minutes off shift to get a chance. A recent event at a Toyota manufacturing facility in Putnam County, West Virginia, resulted in more than 1,000 vaccinations.

Bieber in New Mexico has received similar feedback. He heard from community members that a group of grocers would like to be vaccinated, but they are working on shifts that last beyond the hours their local clinic is open. Mobile vaccination units that give people shots can help with such logistical challenges, he said.

The lack of internet access is another obstacle to getting vaccination appointments, most of which were previously booked online, said Dr. Rupali Limaye, a faculty member at the Johns Hopkins Bloomberg School of Public Health who is involved in vaccine decision making and in state health departments during the vaccine rollout. She said this was particularly evident in states with higher proportions of black residents who are traditionally less likely to have internet access.

Rural communities in West Virginia and New Mexico may also have limited internet access, Hoyer and Bieber said.

public relation

Other barriers to access to vaccines are misinformation or lack of education about the safety of vaccines.

For groups facing more than logistical problems, states turn to community leaders and organizations for help with outreach and education.

New Mexico is working with health care providers to leverage patient relationships to discuss vaccinations. Virtual town halls have also been set up to answer questions from community groups such as the Black and Hispanic residents of the state and the farm laborer population.

City halls usually lead to a surge in vaccine registration, Bieber says, but progress is slower than in the earlier days of the vaccination campaign.

“At a time when we can easily run a mass vaccination event, the point is to convince people by the dozen, dozen, or even one at a time,” he said.

For example, Arkansas works with health professionals, religious and community leaders, and the Chamber of Commerce to disseminate information about vaccines, said Dr. Jennifer Dillaha, epidemiologist and medical director for vaccinations at the state health department. Some people want a familiar, trustworthy environment in which to raise concerns and answer questions, she said.

In East New York, Brooklyn, vaccines were initially not widespread for residents, although they were disproportionately affected by Covid, according to Colette Pean, executive director of the East New York Restoration community organization.

Local residents in the neighborhood have high rates of pre-existing health conditions such as diabetes and asthma, and many are key employees in grocery stores, nursing homes, and the transit department. A New York Times database shows about 20% of residents with at least one dose of vaccine in East New York, compared with 30% in the entire city and more than 40% in many parts of Manhattan.

People want to get the vaccine, Pean said, but need to know where to get it, which is better communicated through a personal approach than a digital one. Her group works in churches, pantries, and subway stations to share information about vaccines and public health issues, Covid and others, that exist in the community.

Johnson & Johnson are taking a break

Earlier this month, the Food and Drug Administration and CDC urged states to temporarily stop using the Johnson & Johnson vaccine “out of caution” after reports that six women had developed rare blood clots. U.S. health officials lifted the 10-day break last week, saying the benefits of the shot outweigh the risk.

So, did the J&J hiatus play a role in the drop in vaccinations? Kates said it wasn’t enough to explain the whole slowdown story.

Only about 8.2 million of the 237 million recordings filed in the US to date are from J&J, although they were used for an average of 425,000 reported recordings per day in mid-April.

The single shot option, which is also easier to transport and store, has proven useful in certain situations and communities, such as: B. in mobile vaccination units and for homeless people who have several difficulties accessing a vaccination center.

“We know that there are some populations who wanted the single dose or were harder to reach and that a single point of contact is ideal, so it is possible that some people were not vaccinated for this reason,” she said. “But on the whole, being a big change is not enough.”

If you only take into account the recordings from Pfizer-BioNTech and Moderna, the downward trend remains. The combination of these two vaccines peaked on April 16, averaging 3 million reported daily shots, and has since declined 13%.

The grimmer question, however, is whether the J&J stop affects confidence in the safety of vaccines in the broader sense and reduces the likelihood of Americans receiving a dose of any of the three vaccine options.

The J&J shot may have been more appealing to those who were initially reluctant to get a vaccine. Polls by the Kaiser Family Foundation in March found that among those who said they’d like to see how the vaccines work before being self-vaccinated, a greater proportion would receive the J&J single-dose vaccine compared to either Dosage options.

However, Kates doesn’t think the J&J hiatus was a major factor behind the vaccine’s hesitation. “As far as I know, the confidence hasn’t been shaken at all,” she said.

Categories
Health

California’s Cal State and UC to require Covid vaccinations for fall semester

California's Cal State and UC to require Covid vaccinations for fall semester

Students on the UC Berkeley campus on March 4, 2020 in Berkeley, California.

Gabrielle Lurie | San Francisco Chronicle | Hearst Newspapers via Getty Images

California State University and the University of California announced Thursday that all students, staff and faculties who want to be on campus must be vaccinated against Covid.

California’s two university systems are the largest of the dozen higher education institutions that require vaccinations for the fall semester. More than 1 million students and employees are affected by the decision. Students and staff can request exemptions for medical or religious reasons, as would be the case with other mandatory vaccines.

“Together, the CSU and UC enroll and employ more than 1 million students and employees on 33 major university campuses. This is the most comprehensive and rigorous university plan for COVID-19 vaccines in the country,” said Cal State Chancellor Joseph I. Castro .

Universities were reluctant to make the decision beforehand due to legal issues surrounding the requirement of vaccines that have not been fully approved by the Food and Drug Administration. Pfizer-BioNTech and Moderna vaccines are sold under emergency clearance, but the companies expect FDA approval by fall.

Both universities plan to work mostly personally for the semester.

Vaccines are “a key step people can take to protect themselves, their friends and family, and our campus communities, while helping end the pandemic,” said UC President Michael V. Drake, a medical doctor.

Some health experts believe that the need for vaccinations for colleges and universities will help stop the spread of Covid among young people who are increasingly at risk for serious illnesses due to variants that mutate and spread rapidly.

California recorded nearly 2,000 new cases of Covid-19 on Wednesday, and a “double mutant” variant of Covid was recently discovered in the state. The state plans to reopen stores by June 15 while maintaining a mask mandate. Almost half of the adults in the state have received at least one dose of a coronavirus vaccine.